Researcher profile
Eduardo Munoz
Affiliations
Organizations
Biomedical Research Instituteauthorship · USCentro Médico Sanitas Córdobaauthorship · ARCordoba Universityauthorship · USHospital Universitario Reina Sofíaauthorship · ESInstitute of Immunology and Physiologyauthorship · RUInstituto Maimónides de Investigación Biomédica de Córdobaauthorship · ESUniversity of Córdobaauthorship · ES
Public evidence
13 connected articles
The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.2023 · Europe PMCMinor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.2022 · Europe PMCFunctional Selectivity of Coumarin Derivates Acting via GPR55 in Neuroinflammation.2022 · Europe PMCA Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (<i>Cannabis sativa</i>).2022 · Europe PMCNeuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson's Disease.2021 · Europe PMCDetrimental Effect of Cannabidiol on the Early Onset of Diabetic Nephropathy in Male Mice.2021 · Europe PMCCannabinoquinones: Synthesis and Biological Profile.2021 · Europe PMCPreclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.2021 · Europe PMCBenefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.2018 · Europe PMCHypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.2018 · Europe PMCAM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity.2017 · Europe PMCVCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.2016 · Europe PMCA cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.2014 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.